Drug combinations with quercetin: Doxorubicin plus quercetin in human breast cancer cells

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 5, 2011, Pages 1161-1172

  Staedler, Davide ^a   Idrizi, Elita ^a   Kenzaoui, Blanka Halamoda ^a   Juillerat Jeanneret, Lucienne ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Breast cancer cells; Doxorubicin; Genotoxicity; Polynucleation; Quercetin; Tyrosine protein kinases

Indexed keywords

DOXORUBICIN; GLUTATHIONE TRANSFERASE; QUERCETIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CELL METABOLISM; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MONOTHERAPY; NUCLEAR SIZE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; COMET ASSAY; DOXORUBICIN; DRUG COMBINATIONS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; QUERCETIN; REACTIVE OXYGEN SPECIES;

EID: 82455192269     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1596-x     Document Type: Article

References (42)

1. GN Hortobagyi 1998 Treatment of breast cancer N Engl J Med 339 974 984 9753714 10.1056/NEJM199810013391407 1:CAS:528:DyaK1cXmslCitrY%3D (Pubitemid 28455101)
2. C Andreetta AM Minisini M Miscoria F Puglisi 2010 First-line chemotherapy with or without biologic agents for metastatic breast cancer Crit Rev Oncol Hematol 76 99 111 20097088 10.1016/j.critrevonc.2010.01.007
3. G Minotti P Menna E Salvatorelli G Cairo L Gianni 2004 Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity Pharmacol Rev 56 185 229 15169927 10.1124/pr.56.2.6 1:CAS:528:DC%2BD2cXltlKgtb0%3D (Pubitemid 38720829)
4. E Gajewski S Gaur SA Akman L Matsumoto JN van Balgooy JH Doroshow 2007 Oxidative DNA base damage in MCF-10A breast epithelial cells at clinically achievable concentrations of doxorubicin Biochem Pharmacol 73 1947 1956 17445777 10.1016/j.bcp.2007.03.022 1:CAS:528:DC%2BD2sXkvFOjur8%3D (Pubitemid 46695716)
5. H Adlercreutz Y Mousavi K Hockerstedt 1992 Diet and breast cancer Acta Oncol 31 175 181 1320387 10.3109/02841869209088899 1:STN:280: DyaK38zit1anug%3D%3D
6. DR Ferry A Smith J Malkhandi DW Fyfe PG deTakats D Anderson J Baker DJ Kerr 1996 Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin Cancer Res 2 659 668 9816216 1:CAS:528:DyaK28Xis1Wltbg%3D (Pubitemid 26133468)
7. YJ Moon L Wang R DiCenzo ME Morris 2008 Quercetin pharmacokinetics in humans Biopharm Drug Dispos 29 205 217 18241083 10.1002/bdd.605 1:CAS:528:DC%2BD1cXntVemsLg%3D (Pubitemid 351802843)
8. EH Rodgers MH Grant 1998 The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells Chem Biol Interact 116 213 228 9920463 10.1016/S0009- 2797(98)00092-1 1:CAS:528:DyaK1cXnsFWlu78%3D (Pubitemid 28543195)
9. S Paliwal J Sundaram S Mitragotri 2005 Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound Br J Cancer 92 499 502 15685239 1:CAS:528:DC%2BD2MXhtFWntrY%3D (Pubitemid 40395530)
10. L Wang YC Tu TW Lian JT Hung JH Yen MJ Wu 2006 Distinctive antioxidant and antiinflammatory effects of flavonols J Agric Food Chem 54 9798 9804 17177504 10.1021/jf0620719 1:CAS:528:DC%2BD28Xht1anur%2FL (Pubitemid 46158973)
11. A Bach J Bender-Sigel D Schrenk D Flugel K Kietzmann 2010 The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF Antioxid Redox Signal 13 437 448 19958256 10.1089/ars.2009.3000 1:CAS:528:DC%2BC3cXot1aksL4%3D
12. T Kawahara N Kawaguchi-Ihara Y Okuhashi M Itoh N Nara S Tohda 2009 Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells Anticancer Res 29 4629 4632 20032413 1:CAS:528:DC%2BC3cXptlersQ%3D%3D
13. S Caltagirone C Rossi A Poggi FO Ranelletti PG Natali M Brunetti FM Aiello M Piantelli 2000 Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential Int J Cancer 87 595 600 10918203 10.1002/1097-0215(20000815)87:4<595::AID-IJC21>3.0.CO;2-5 1:CAS:528:DC%2BD3cXlvVyms7o%3D (Pubitemid 30639822)
14. TC Hsieh JM Wu 2009 Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin Anticancer Res 29 4025 4032 19846946 1:CAS:528:DC%2BD1MXhsVOlt7bI
15. R Ferraresi L Troiano E Roat E Lugli E Nemes M Nasi M Pinti MI Fernandez EL Cooper A Cossarizza 2005 Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin Free Radic Res 39 1249 1258 16298752 10.1080/10715760500306935 1:CAS:528:DC%2BD2MXht1agtrnN (Pubitemid 41601428)
16. HW Lo F Ali-Osman 2007 Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance Curr.Opin. Pharmacol. 7 367 374 17681492 10.1016/j.coph.2007.06.009 1:CAS:528:DC%2BD2sXpsFKqsrk%3D (Pubitemid 47289267)
17. S Tsuchida K Sato 1992 Glutathione transferases and cancer Crit Rev Biochem Mol Biol 27 337 384 1521461 10.3109/10409239209082566 1:CAS:528:DyaK3sXitVShtg%3D%3D
18. JD Hayes JU Flanagan IR Jowsey 2005 Glutathione transferases Ann Rev Pharmacol Toxicol 45 51 88 10.1146/annurev.pharmtox.45.120403.095857 1:CAS:528:DC%2BD2MXisVWjtrk%3D (Pubitemid 40261798)
19. M Perquin T Oster A Maul N Froment M Untereiner D Bagrel 2000 The glutathione-related detoxification pathway in the human breast: a highly coordinated system disrupted in the tumour tissues Cancer Lett 158 7 16 10940503 10.1016/S0304-3835(00)00481-X 1:CAS:528:DC%2BD3cXlsFCju7k%3D (Pubitemid 30625225)
20. SH Akbas M Timur T Ozben 2005 The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells J Surg Res 125 125 49 55 15836850 10.1016/j.jss.2004.11.011 1:CAS:528:DC%2BD2MXjt1Wjt7c%3D (Pubitemid 40523775)
21. A Schlachterman F Valle KM Wall NG Azios L Castillo L Morell AV Washington LA Cubano SF Dharmawardhane 2008 Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model Transl Oncol 1 19 27 18607509
22. G Du H Lin M Wang S Zhang X Wu L Lu L Ji L Yu 2010 Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1alpha in tumor and normal cells Cancer Chemother Pharmacol 65 277 287 19466611 10.1007/s00280-009-1032-7 1:CAS:528: DC%2BD1MXhsVKnsL%2FJ
23. G Du H Lin Y Yang S Zhang X Wu M Wang L Ji L Lu L Yu G Han 2010 Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice Int Immunopharmacol 10 819 826 20447470 10.1016/j.intimp.2010.04.018 1:CAS:528:DC%2BC3cXntVagt78%3D
24. R Vaclavikova E Kondrova M Ehrlichova A Boumendjel J Kovar P Stopka P Soucek I Gut 2008 The effect of flavonoid derivatives on doxorubicin transport and metabolism Bioorg Med Chem 16 2034 2042 18024139 10.1016/j.bmc.2007.10.093 1:CAS:528:DC%2BD1cXitVOisbc%3D (Pubitemid 351226568)
25. L Juillerat-Jeanneret C Chapuis Bernasconi C Bricod S Gros S Trepey J Benhattar RC Janzer 2008 Heterogeneity of human glioblastoma: glutathione-S-transferase and methylguanine methyl transferase Cancer Invest 26 597 608 18584351 10.1080/07357900802072913 1:CAS:528:DC%2BD1cXnsl2rtL4%3D (Pubitemid 351918586)
26. AR Collins 2004 The comet assay for DNA damage and repair: principles, applications, and limitations Mol Biotechnol 26 249 261 15004294 10.1385/MB:26:3:249 1:CAS:528:DC%2BD2cXivF2gu7c%3D (Pubitemid 41490465)
27. GM Nagaraja M Othman BP Fox R Alsaber CM Pellegraino Y Zeng R Khanna P Tamburini A Swaroop RP Kandpal 2006 Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics Oncogene 25 2328 2338 16314837 10.1038/sj.onc.1209265 1:CAS:528:DC%2BD28XjsVWku7g%3D
28. K Wang S Ramji A Bhathena C Lee DS Riddick 1999 Glutathione S-transferase in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines Xenobiotica 29 155 170 10199592 10.1080/004982599238713 1:CAS:528: DyaK1MXhs1Cisbo%3D (Pubitemid 29103586)
29. DA Gewirtz 1999 A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem Pharmacol 57 727 741 10075079 10.1016/S0006-2952(98) 00307-4 1:CAS:528:DyaK1MXhsFeksL8%3D (Pubitemid 29094544)
30. Z Topcu 2001 DNA topoisomerases as targets for anticancer drugs J Clin Pharm Ther 26 405 416 11722677 10.1046/j.1365-2710.2001.00368.x 1:CAS:528:DC%2BD3MXpt1Wjsrk%3D (Pubitemid 34205966)
31. RM Momparler M Karon SE Siegel F Avila 1976 Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells Cancer Res 36 2891 2895 1277199 1:STN:280:DyaE283gvVWqtw%3D%3D
32. Diaz Bessone MI, Berardi DE, Campodonico PB, Todaro LB, Lothstein L, Bal de Kier Joffe ED, Urtreger AJ (2010) Involvement of PKC delta (PKCdelta) in the resistance against different doxorubicin analogs. Breast Cancer Res Treat (in press)
33. CMJ Conklin JF Bechberger D MacFabe N Guthrie EM Kurowska CC Naus 2007 Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells Carcinogenesis 28 93 100 16777995 10.1093/carcin/bgl106 1:CAS:528:DC%2BD28XhtlChtbvJ (Pubitemid 44942630)
34. JJ van Zanden O Ben Hamman ML van Iersel S Boeren NH Cnubben M Lo Bello J Vervoort PJ van Bladeren IM Rietjens 2003 Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin Chem Biol Interact 145 139 148 12686490 10.1016/S0009-2797(02)00250-8 (Pubitemid 36398427)
35. HO Gutzeit Y Henker B Kind A Franz 2004 Specific interactions of quercetin and other flavonoids with target proteins are revealed by elicited fluorescence Biochem Biophys Res Commun 318 490 495 15120627 10.1016/j.bbrc.2004.04.078 1:CAS:528:DC%2BD2cXjs1Cjs7k%3D (Pubitemid 38553806)
36. A Murakami H Ashida J Terao 2008 Multitargeted cancer prevention by quercetin Cancer Lett 269 315 325 18467024 10.1016/j.canlet.2008.03.046 1:CAS:528:DC%2BD1cXhtFWlsrjE
37. Q Cai RO Rahn R Zhang 1997 Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals Cancer Lett 119 99 107 18372528 10.1016/S0304-3835(97)00261-9 1:CAS:528:DyaK2sXmslWlsbc%3D (Pubitemid 27464671)
38. JS Biscardi RC Ishizawar CM Silva SJ Parsons 2000 Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer Breast Cancer Res 2 203 210 11250711 10.1186/bcr55 1:CAS:528:DC%2BD3cXls1Sltb0%3D (Pubitemid 32223586)
39. KW Lee NJ Kang YS Heo EA Rogozin A Pugliese MK Hwang GT Bowden AM Bode HJ Lee Z Dong 2008 Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine Cancer Res 68 946 955 18245498 10.1158/0008-5472.CAN-07-3140 1:CAS:528: DC%2BD1cXhtlygur0%3D (Pubitemid 351206774)
40. PJ Roberts CJ Der 2007 Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer Oncogene 26 3291 3310 17496923 10.1038/sj.onc.1210422 1:CAS:528:DC%2BD2sXlt1Wktb4%3D (Pubitemid 46763022)
41. RL Singhal YA Yeh N Praja E Olah GW Sledge G Weber 1995 Quercetin down-regulates signal transduction in human breast carcinoma cells Biochem Biophys Res Commun 208 425 431 7887960 10.1006/bbrc.1995.1355 1:STN:280:DyaK2M7psVCnsA%3D%3D
42. CW Lin WC Hou SC Shen SH Juan CH Ko LM Wang YC Chen 2008 Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells Carcinogenesis 29 1807 1815 18628248 10.1093/carcin/bgn162 1:CAS:528:DC%2BD1cXhtV2jsLzO